No Data
No Data
UnitedHealth Q1 Disappoints, But These Analysts Remain Bullish On The Stock
UnitedHealth Spent No Money on Security for Slain Executive Thompson in 2024
SA Asks: What's the Most Attractive Medtech Stock Right Now?
$1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today
Gilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer
Novo Nordisk Has Sought Approval of Oral Version of Wegovy - Report
Cui Nyonya Kueh OP : Got cure, no sick.